BioSpecifics Technologies Corp. to Present at CapStone Investments' Third Annual Small-Cap Investor Conference
LYNBROOK, N.Y., July 22 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming CapStone Inve...
Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results
PALO ALTO, Calif., July 21,/PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) plans to release its financial results for the third
quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, July 29, 2009. A live webcast (in listen-only mode) of its investor conf...
Nano measurement in the third dimension
This release is available in German .
From the motion sensor to the computer chip - in many products of daily life components are used whose functioning is based on smallest structures of the size of thousandths - or even millionths - of millimetres. These micro and nano structures must be...
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
FRANKLIN LAKES, N.J., June 29 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ) announced today that it will conduct a live webcast of its third
fiscal quarter 2009 earnings conference call on Thursday, July 30, 2009 at 10:00 a.m. (EDT). BD will issue a press release d...
WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE:
WX ) today announced that Edward Hu, the Company's Chief Operating Officer and
acting Chief Financial Officer, will present at the Third
Healthcare Conference in New York on Wednesday, June 17, 2009,...
Delcath Systems Granted Third Orphan Drug Designation
NEW YORK, June 2 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that the United States Food and Drug Administration ("FDA") granted Delcath's a...
China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results
GANSU, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Dasheng
Biotechnology Company ("China Dasheng" or "the Company") (OTC Bulletin Board:
CDBT), a leading producer and distributor of organic bacteria based additives
for crops and livestock feeds in the PRC, announced unaudited financial
Corgenix Reports Third Quarter Fiscal 2009 Financial Results
- Revenues for the quarter increase 4.2% vs. prior year -
DENVER, May 14 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its third
quarter Form 10-Q and reported financial results. The r...
YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
MISSISSAUGA, ON, May 14 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI , TSX:YM, AIM:YMBA), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported operational ...
ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program
CLEVELAND, May 6 /PRNewswire/ -- ChanTest, the leading expert in ion channels and GPCRs (G-protein coupled receptors) -- key to drug discovery, development, and safety -- is one of eight organizations slated to receive funding through Ohio's Third
Frontier Research and Commercialization Program. G...
Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
NEW BRUNSWICK, N.J., May 4 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today reported financial results for the three months ended March 31, 2009.
Net loss for the three month period ended March 31, 2009 was $1,331,477, or $0.07 pe...
Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
MINNEAPOLIS, April 28 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH ) consolidated net earnings for the quarter ended March 31, 2009 decreased 6.6% to $27.6 million or $.74 per diluted share compared with $29.6 million or $.76 per diluted share for the quarter ended March 31, 2008...
PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
- Consolidated service revenue of $264.5 million grows 7.8% year-over-year
- Operating margin of 10.0%
- Diluted earnings per share of $0.25
- Net quarterly book-to-bill ratio equates to 1.25
BOSTON, April 27 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: ...
Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results
LAVAL, QC, April 14 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) provides guidance for the expected financial results of the fiscal 2009 third
quarter and nine-month period ended February 28, 2009. These results represent the year-end...
Neogen Reports Record Third Quarter
LANSING, Mich., March 19 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG ) announced today that despite obstacles posed by the declining global economy, its third
quarter revenues increased 11% to $27,840,000, a record third
quarter for the 26-year-old company, compared to the prior y...
Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
BALTIMORE, March 18 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, reports its financial results for the third
fiscal quarter ...
US Oncology Named to FORTUNE Magazine's Most Admired Companies List for Third Time
HOUSTON, March 12 /PRNewswire/ -- US Oncology, Inc ., one of the nation's largest cancer care services companies, has been named to FORTUNE magazine's Most Admired Companies list for 2009. The company ranks third
in the Health Care: Pharmacy and Other category. This is the third
time US On...
Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon
SUNNYVALE, Calif., Feb. 17 /PRNewswire/ -- Avantis Medical Systems, Inc., a technology leader in developing novel chip-on-catheter digital imaging devices, announced today that it has received a new 510(k) clearance for its Third
Eye(R) Retroscope(R) (Third Eye), supporting the claim for increased...
On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
ANN ARBOR, Mich., Feb. 10 /PRNewswire/ -- Compendia Bioscience, Inc. today announced the results of a third
productive year, including a 100 percent renewal rate from its customers. New customers and increased commitments from existing customers, including multi-year agreements from three of the T...
Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008
TOKYO, February 5 /PRNewswire-FirstCall/ -- HOYA Corporation today
announced financial results for the third
quarter ended December 31, 2008.
Net sales were 112.7 billion yen for the quarter, representing a decrease of
23.3% from 147.0 billion yen in the third
quarter of 2007, mainly due to
Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
WALTHAM, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today reported results for the third
quarter of fiscal year 2009, ended December 31, 2008. Total revenue for the quarter was $6,018,000 compared to $4,664,000 for the third
quarter of fiscal year 2008. Total ...
Uroplasty Reports Third Quarter Fiscal 2009 Results
MINNEAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI ),
a medical device company that develops, manufactures and markets innovative
proprietary products to treat voiding dysfunctions, today reported financial
results for the third
quarter of fiscal 2009 ended December 31,...
Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
Thursday, February 5th, 10:00 a.m. EST
WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, February 5th,...
Abaxis to Report Third Quarter Fiscal 2009 Financial Results Thursday, January 29, 2009
UNION CITY, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the third
quarter of fiscal year 2009, ended December 31, 2008. ...
Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
REHOVOT, Israel, JERSEY CITY, New Jersey and PHILADELPHIA, Pennsylvania,
December 29 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG),
the leading developer of microRNA-based molecular diagnostics, announced
today the introduction of its third
diagnostic test, miRview(TM) meso. T...
Probiotic Delivery Technology Awarded Third International Patent
REDMOND, Wash., Dec. 16 /PRNewswire/ -- The Australian Patent Office has
issued Nutraceutix, Inc. a patent for BIO-tract. It is the third
patent, from many patents pending, that the technology has been awarded based
on BIO-tract's ability to protect sensitive ingredients like probiot...
Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
REHOVOT, Israel and JERSEY CITY, New Jersey, December 5
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG ), an
innovative molecular diagnostic company leveraging microRNAs as biomarkers,
reported today its consolidated financial results for the quarter ended
September 30, 2008 ...
Ernst & Young Benchmarks Danish Biotech Pipeline Third in Europe
COPENHAGEN, December 1 /PRNewswire/ -- A strong pipeline makes the
Copenhagen Region biotech cluster well prepared for the challenges ahead.
With 185 drug candidates in preclinical and clinical development, Denmark
in Europe. Only United Kingdom and Germany have a bigger pipeline.
Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
WAYNE, Pa., Nov. 28 /PRNewswire-FirstCall/ -- Encorium Group, Inc.
(Nasdaq: ENCO ), a full service multinational clinical research organization
(CRO) conducting studies in over 30 countries for many of the world's leading
pharmaceutical and biotechnology companies, today announced that on Novemb...
Encorium Reports Third Quarter 2008 Financial Results
-- New business wins increase 400% to $16 million in third
quarter 2008; up 40% year-to-date
-- Results include $1.9 million non-cash goodwill impairment charge
WAYNE, Pa., Nov. 26 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ) , a full service multinational c...
Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
REHOVOT, Israel and JERSEY CITY, New Jersey, November 26
/PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG ), today announced it
will release third
quarter financial results on December 5, 2008, before the
U.S. markets open. Rosetta Genomics will host a conference call with a
Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results
LA JOLLA, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Duska Therapeutics,
Inc. (OTC Bulletin Board: DSKA) will host a teleconference call today at
2:30 p.m. EST to review its drug development programs and financial results
for the third
quarter of 2008. Duska's chief executive officer, James S. Kuo,...
Sinovac Reports Third Quarter 2008 Unaudited Financial Results
BEIJING, Nov. 18 /PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA ), a
leading developer and provider of vaccines in China, today announced the
Company's financial results for the three-month and nine-month periods ended
September 30, 2008.
-- Sales year-to-date increased ...
Benda Pharmaceutical Reports Third Quarter 2008 Financial Results
HUBEI PROVINCE, China, Nov. 18 /PRNewswire-FirstCall/ --
Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based
pharmaceutical company producing both Gendicine(R), a commercialized gene
therapy medicine for the treatment of cancer, and traditional Chinese and
conventional medicines, ...
Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
Conference Call To Be Held Friday, November 14, 2008 at 9:00 a.m. Eastern Time
HOPKINTON, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Alseres
Pharmaceuticals, Inc. (Nasdaq: ALSE ) today reports operational and
financial results for the quarter ended September 30, ...
Pharmathene Reports Third Quarter 2008 Financial and Operational Results
ANNAPOLIS, Md., Nov. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
(NYSE Alternext US: PIP), a biodefense company developing medical
countermeasures against biological and chemical threats, today reported
financial and operational results for the third
quarter and nine months
ended September ...
Interleukin Genetics Reports Third Quarter 2008 Financial Results
WALTHAM, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics,
Inc. (Amex: ILI ) today announced financial and business results for the
third quarter ended September 30, 2008.
The Company reported a net loss of $1.6 million, or $(.05) per basic
and diluted common share, for the thi...
Cardiogenesis Reports Third Quarter 2008 Results
IRVINE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Cardiogenesis
Corporation (Pink Sheets: CGCP), a leading developer of surgical products
used in the treatment of patients suffering from severe angina, today
reported financial results for its third
quarter ended September 30, 2008.
AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
All amounts are in U.S. dollars
QUEBEC CITY, Nov. 13 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.
(NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on
endocrinology and oncology, today reported financial and operating results
for the third
quarter ended September 30, 2...
Yongye Biotechnology Announces Record Third Quarter Results
BEIJING, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology
International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"),
a leading developer, producer and distributor of nutrients for plants and
animals in the People's Republic of China, today announced its financial